EXHIBIT BDocola, Inc. • November 20th, 2023 • Services-computer processing & data preparation • New York
THIS NON-TRADEABLE COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [●], 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [●], 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Docola, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is one of the non-tradeable warrants to purchase common stock issued pursuant to (i) the first paragraph of that certain Underwriting Agreement (defined below) and (ii) the Registration Statement (defined below). This Warrant shall initial
docola, Inc. Executive Employment Agreement Dated as of November ___, 2023Executive Employment Agreement • November 20th, 2023 • Docola, Inc. • Services-computer processing & data preparation • Florida
This Executive Employment Agreement (the “Agreement”) dated as of the date first set forth above (the “Effective Date”) is entered into by and between docola, Inc., a Delaware corporation (the “Company”) and Tomer Kabakov (the “Executive”). The Company and Executive may collective be referred to as the “Parties” and each individually as a “Party”.
DOCOLA, INC. UNDERWRITING AGREEMENT [●] UNITS, EACH UNIT CONSISTING OF ONE SHARE OF COMMON STOCK AND TWO WARRANTS; EACH WARRANT TO PURCHASE ONE SHARE OF COMMON STOCKUnderwriting Agreement • November 20th, 2023 • Docola, Inc. • Services-computer processing & data preparation • New York
DOCOLA, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as representative (the “Representative”), an aggregate of [●]units (“Units”) at an initial public offering price of $[●] per Unit . Each Unit will consist of: (i) one share of the Company’s common stock, $0.0001 par value per share (the “Common Stock”); (ii) one five year tradeable warrant (“Tradeable Warrant”) to purchase one share of Common Stock at an exercise price equal to $[●] per share of Common Stock ; and one five year non-tradeable warrant (“Non-Tradeable Warrant”) to purchase one share of Common Stock (“Warrant Shares”) at an exercise price equal to $[●] per share of Common Stock. The Tradeable Warrant and the Non-Tradeable Warrant are referred to herein together as the “Warrants” and the shares of Common S
MASTER SERVICES AGREEMENTMaster Services Agreement • October 10th, 2023 • Docola, Inc. • Services-computer processing & data preparation • Florida
Geri Lynn Baumblatt working as Articulations Consulting DBA Hyperjeff Inc (“Consultant”), whose principal place of business is located at ██████████████ Chicago, IL █████.
MASTER SERVICES AGREEMENTCertain Confidential • October 10th, 2023 • Docola, Inc. • Services-computer processing & data preparation • Quebec
This Agreement is effective as of December 9, 2021 by and between AbbVie Corporation, a corporation under the laws of Canada and having its principal place of business at 8401 Trans- Canada Highway, St-Laurent, Quebec, Canada H4S 1Z1 (“AbbVie”) and Docola Inc., having a mailing address of 801 West Bay Dr, Largo, FL, 33770-3220 (“Service Provider”, collectively with AbbVie, the “Parties” or individually a “Party”).
AMENDMENT TO MASTER SERVICES AGREEMENTMaster Services Agreement • October 10th, 2023 • Docola, Inc. • Services-computer processing & data preparation
This first amendment (“Amendment”) is dated as of March 4, 2022 (the “Effective Date”) by and between ABBVIE CORPORATION, a corporation under the laws of Canada and having its principal place of business at 8401 Trans-Canada Highway, St-Laurent, Quebec, Canada H4S 1Z1 (“AbbVie”) and DOCOLA INC., having a mailing address of 801 West Bay Dr, Largo, FL, 337703220 (“Service Provider”, collectively with AbbVie, the “Parties” or individually a “Party”).
Memorandum of Understanding Between Docola and Patients for Patient Safety United StatesDocola, Inc. • September 8th, 2023 • Services-computer processing & data preparation
Memorandum of Understanding Between Docola and Patients for Patient Safety United StatesDocola, Inc. • January 23rd, 2023 • Services-computer processing & data preparation
FORM OF WARRANT AGENT AGREEMENTWarrant Agent Agreement • November 20th, 2023 • Docola, Inc. • Services-computer processing & data preparation
This Warrant Agent Agreement (this “Warrant Agreement”), dated as of [●], 2023 (the “Issuance Date”) is between Docola, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), and VStock Transfer, LLC, a California limited liability company (the “Warrant Agent”).
LICENSE AGREEMENTLicense Agreement • January 23rd, 2023 • Docola, Inc. • Services-computer processing & data preparation • Colorado
This Commercial Use License Agreement, including the Schedules (hereinafter referred to as “Agreement”), is effective this 1st day of September, 2019 (“Effective Date”), by and between Visual Health Solutions, Inc., a Colorado corporation having a primary place of business at 300 Boardwalk Dr., Suite 4B, Fort Collins, Colorado 80525, (hereinafter referred to as “Licensor” or “Visual”), and Docola, Inc. with offices located at 801 West Bay Dr. #506, Largo, FL 33770 (hereinafter referred to as “Licensee” or Doc.la).
COLLABORATIVE AGREEMENT SANO GENETICS AND DOCOLA INC.Collaborative Agreement • January 23rd, 2023 • Docola, Inc. • Services-computer processing & data preparation
This collaborative agreement (“Agreement”) dated 2nd of August 2022, is between Sano Genetics Limited (“Sano Genetics”) with a company number of 10636359 and a registered address of Salisbury House, Station Rd, Cambridge CB1 2LA, and Docola Inc. (“Partner”), with a company tax identification number of 46-3626795 and a permanent address of 801 W Bay Dr. STE 506, Largo FL 33770.
AMENDMENT TO MASTER SERVICES AGREEMENTMaster Services Agreement • November 20th, 2023 • Docola, Inc. • Services-computer processing & data preparation
This first amendment (“Amendment”) is dated as of March 4, 2022 (the “Effective Date”) by and between ABBVIE CORPORATION, a corporation under the laws of Canada and having its principal place of business at 8401 Trans-Canada Highway, St-Laurent, Quebec, Canada H4S 1Z1 (“AbbVie”) and DOCOLA INC., having a mailing address of 801 West Bay Dr, Largo, FL, 337703220 (“Service Provider”, collectively with AbbVie, the “Parties” or individually a “Party”).
